Secondaries Announced 9.20.17

IPO BOUTIQUE CLIENTS and IPO BOUTIQUE SECONDARY ALERTS CLIENTS received ALL this information to their inbox on a REAL TIME basis.

If having real-time alerts for secondary offerings would be an advantage to you, inquire about a subscription today!

Our Buy, Neutral or Avoid ratings of the Secondaries below are intended as a recommendation for those who buy Secondaries on a regular basis. For example, this is not to be interpreted as a Buy recommendation in the traditional sense of adding to your stock portfolio; this is a short term (usually one day or opening trade) time period.

Company: Juno Therapeutics
Symbol: JUNO
Price: Last Trade $45.21
Trade Date: 9/22
Shares: 5.0 million ($225m cash raise)
Underwriter(s) : Morgan Stanley, J.P. Morgan
Co-Manager(s): Barclays, Wells Fargo Securities, Raymond James, Leerink Partners, Wedbush PacGrow
Description: Juno Therapeutics is building a fully integrated biopharmaceutical company focused on developing innovative cellular immunotherapies for the treatment of cancer.
Rating = Subscription Needed

Company: Veon Ltd.
Symbol: VEON
Price: Last Trade $4.18
Trade Date: 9/21
Shares: 90.0 million
Re-Offer Range: Subscription Needed
Underwriter(s) : Citigroup, Morgan Stanley
Description: VEON is a global provider of telecommunication services founded in 2009, incorporated in Bermuda and headquartered in Amsterdam.
Rating = Subscription Needed